Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study. Papi, A., Chipps, B. E., Beasley, R., Panettieri, R. A., Israel, E., Cooper, M., Dunsire, L., Jeynes-Ellis, A., Rees, R., Albers, F. C., & Cappelletti, C. Therapeutic Advances in Respiratory Disease, 18:17534666241232264, January, 2024.
Paper doi abstract bibtex What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.
@article{papi_albuterolbudesonide_2024,
title = {Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the {MANDALA} study},
volume = {18},
issn = {1753-4666, 1753-4666},
shorttitle = {Albuterol–budesonide fixed-dose combination rescue inhaler for asthma},
url = {https://journals.sagepub.com/doi/10.1177/17534666241232264},
doi = {10.1177/17534666241232264},
abstract = {What is this summary about?
This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.},
language = {en},
urldate = {2024-08-11},
journal = {Therapeutic Advances in Respiratory Disease},
author = {Papi, Alberto and Chipps, Bradley E. and Beasley, Richard and Panettieri, Reynold A. and Israel, Elliot and Cooper, Mark and Dunsire, Lynn and Jeynes-Ellis, Allison and Rees, Robert and Albers, Frank C. and Cappelletti, Christy},
month = jan,
year = {2024},
pages = {17534666241232264},
}
Downloads: 0
{"_id":"4jkhjWcxaLNFNDvg4","bibbaseid":"papi-chipps-beasley-panettieri-israel-cooper-dunsire-jeynesellis-etal-albuterolbudesonidefixeddosecombinationrescueinhalerforasthmaaplainlanguagesummaryofthemandalastudy-2024","author_short":["Papi, A.","Chipps, B. E.","Beasley, R.","Panettieri, R. A.","Israel, E.","Cooper, M.","Dunsire, L.","Jeynes-Ellis, A.","Rees, R.","Albers, F. C.","Cappelletti, C."],"bibdata":{"bibtype":"article","type":"article","title":"Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study","volume":"18","issn":"1753-4666, 1753-4666","shorttitle":"Albuterol–budesonide fixed-dose combination rescue inhaler for asthma","url":"https://journals.sagepub.com/doi/10.1177/17534666241232264","doi":"10.1177/17534666241232264","abstract":"What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.","language":"en","urldate":"2024-08-11","journal":"Therapeutic Advances in Respiratory Disease","author":[{"propositions":[],"lastnames":["Papi"],"firstnames":["Alberto"],"suffixes":[]},{"propositions":[],"lastnames":["Chipps"],"firstnames":["Bradley","E."],"suffixes":[]},{"propositions":[],"lastnames":["Beasley"],"firstnames":["Richard"],"suffixes":[]},{"propositions":[],"lastnames":["Panettieri"],"firstnames":["Reynold","A."],"suffixes":[]},{"propositions":[],"lastnames":["Israel"],"firstnames":["Elliot"],"suffixes":[]},{"propositions":[],"lastnames":["Cooper"],"firstnames":["Mark"],"suffixes":[]},{"propositions":[],"lastnames":["Dunsire"],"firstnames":["Lynn"],"suffixes":[]},{"propositions":[],"lastnames":["Jeynes-Ellis"],"firstnames":["Allison"],"suffixes":[]},{"propositions":[],"lastnames":["Rees"],"firstnames":["Robert"],"suffixes":[]},{"propositions":[],"lastnames":["Albers"],"firstnames":["Frank","C."],"suffixes":[]},{"propositions":[],"lastnames":["Cappelletti"],"firstnames":["Christy"],"suffixes":[]}],"month":"January","year":"2024","pages":"17534666241232264","bibtex":"@article{papi_albuterolbudesonide_2024,\n\ttitle = {Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the {MANDALA} study},\n\tvolume = {18},\n\tissn = {1753-4666, 1753-4666},\n\tshorttitle = {Albuterol–budesonide fixed-dose combination rescue inhaler for asthma},\n\turl = {https://journals.sagepub.com/doi/10.1177/17534666241232264},\n\tdoi = {10.1177/17534666241232264},\n\tabstract = {What is this summary about? \n This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol–budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.},\n\tlanguage = {en},\n\turldate = {2024-08-11},\n\tjournal = {Therapeutic Advances in Respiratory Disease},\n\tauthor = {Papi, Alberto and Chipps, Bradley E. and Beasley, Richard and Panettieri, Reynold A. and Israel, Elliot and Cooper, Mark and Dunsire, Lynn and Jeynes-Ellis, Allison and Rees, Robert and Albers, Frank C. and Cappelletti, Christy},\n\tmonth = jan,\n\tyear = {2024},\n\tpages = {17534666241232264},\n}\n\n","author_short":["Papi, A.","Chipps, B. E.","Beasley, R.","Panettieri, R. A.","Israel, E.","Cooper, M.","Dunsire, L.","Jeynes-Ellis, A.","Rees, R.","Albers, F. C.","Cappelletti, C."],"key":"papi_albuterolbudesonide_2024","id":"papi_albuterolbudesonide_2024","bibbaseid":"papi-chipps-beasley-panettieri-israel-cooper-dunsire-jeynesellis-etal-albuterolbudesonidefixeddosecombinationrescueinhalerforasthmaaplainlanguagesummaryofthemandalastudy-2024","role":"author","urls":{"Paper":"https://journals.sagepub.com/doi/10.1177/17534666241232264"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/users/6607533/collections/34TFFZQV/items?key=hSjrOPQRRHHWY81SKs6CEz45&format=bibtex&limit=100","dataSources":["AxsrLkzeAo8Y8KauF","mSXLJgYNdKnSRXmnZ"],"keywords":[],"search_terms":["albuterol","budesonide","fixed","dose","combination","rescue","inhaler","asthma","plain","language","summary","mandala","study","papi","chipps","beasley","panettieri","israel","cooper","dunsire","jeynes-ellis","rees","albers","cappelletti"],"title":"Albuterol–budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study","year":2024}